CLASSIC HODGKIN LYMPHOMA

Clinical trials for CLASSIC HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 4 Terminated 1

Experimental lymphoma drug trial halted early

Disease control Terminated

This study tested an experimental drug called SAR444245, both alone and combined with other cancer treatments, for people with advanced B-cell lymphoma that had returned or stopped responding to previous therapies. It involved 14 participants aged 12 and older who had already tri…

Matched conditions: CLASSIC HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control

Last updated Apr 01, 2026 20:11 UTC

CLASSIC HODGKIN LYMPHOMA

Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear

Experimental lymphoma drug trial halted early